A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer (Q39903605)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer |
scientific article |
Statements
1 reference
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer (English)
1 reference
Andrew H Ko
1 reference
Alan P Venook
1 reference
Emily K Bergsland
1 reference
R Kate Kelley
1 reference
W Michael Korn
1 reference
Elizabeth Dito
1 reference
Brian Schillinger
1 reference
Janet Scott
1 reference
Jimmy Hwang
1 reference
Margaret A Tempero
1 reference
4 February 2010
1 reference
1 reference
66
1 reference
6
1 reference
1051-1057
1 reference
Identifiers
1 reference
1 reference